Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $12.26, but opened at $11.68. Santen Pharmaceutical shares last traded at $11.68, with a volume of 282 shares trading hands.
Santen Pharmaceutical Trading Down 4.7%
The business’s 50 day moving average is $12.52 and its 200 day moving average is $11.68.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Featured Articles
- Five stocks we like better than Santen Pharmaceutical
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
- Permian Resources Rally Faces a Test
- Google Cloud Just Gave Rezolve AI a Major Vote of Confidence
- Strategy’s $1.59B Gamble: Checkmate at $80K?
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
